Stephen Mitchener - 02 Dec 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, Chief Business Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stephen Mitchener
Issuer symbol
KPTI
Transactions as of
02 Dec 2021
Net transactions value
-$3,338
Form type
4
Filing time
03 Dec 2021, 17:17:28 UTC
Previous filing
03 Jun 2021
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $3,338 -499 -13% $6.69 3,296 02 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary sale by the reporting person.
F2 Includes 1,323 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021.